Mass Spectrometry-Based Identification of a B-Cell Maturation Antigen-Derived T-Cell Epitope for Antigen-Specific Immunotherapy of Multiple Myeloma

Blood Cancer Journal - United States
doi 10.1038/s41408-020-0288-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Chimeric Antigen Receptor T Cell Targeting B Cell Maturation Antigen Immunotherapy Is Promising for Multiple Myeloma

Annals of Hematology
MedicineHematology
2019English

Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma

International Journal of Hematology
Hematology
2020English

Chimeric Antigen Receptor T Cell Therapies for Multiple Myeloma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Selective Antigen-Specific CD4+T-cell, but Not CD8+T- Or B-Cell, Tolerance Corrupts Cancer Immunotherapy

European Journal of Immunology
AllergyImmunology
2014English

Cell-Based Immunotherapy Approaches for Multiple Myeloma

British Journal of Cancer
Cancer ResearchOncology
2018English

Chimaeric Antigen Receptor T-Cell Therapy for Tumour Immunotherapy

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2017English

Nanoscale Artificial Antigen Presenting Cells for T Cell Immunotherapy

Nanomedicine: Nanotechnology, Biology, and Medicine
Materials ScienceMolecular MedicineNanosciencePharmaceutical ScienceMedicineBioengineeringNanotechnologyBiomedical Engineering
2014English

Total Costs of Chimeric Antigen Receptor T-Cell Immunotherapy

JAMA Oncology
Cancer ResearchOncology
2018English

MHC-based Detection of Antigen-Specific CD8+ T Cell Responses

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy